13 min listen
Type 2 Diabetes Treatment - Part 6 - SGLT2 Inhibitors
Type 2 Diabetes Treatment - Part 6 - SGLT2 Inhibitors
ratings:
Length:
20 minutes
Released:
Sep 26, 2018
Format:
Podcast episode
Description
Sodium-Glucose Transporter 2 Inhibitors decrease glucose re-absorbtion. The diuretic effect, weight loss, DKA, cardiac outcomes, blood pressure, genital infections and a whole bunch of other information is discussed.
SGLT2s include Canagliflozin (Invokana), Dapagliflozin (Farxiga), Empagliflozin (Jardiance), Ertagliflozin (Steglatro), with more to be released in the future.
SGLT2s include Canagliflozin (Invokana), Dapagliflozin (Farxiga), Empagliflozin (Jardiance), Ertagliflozin (Steglatro), with more to be released in the future.
Released:
Sep 26, 2018
Format:
Podcast episode
Titles in the series (100)
Renal and Ureteral Stones (Nephrolithiasis - Kidney Stones) - part 4: Oxalate intake reduction, thiazide diuretics, and tamsulosin are some of the therapies discussed in this lecture. by Hospital and Internal Medicine Podcast